| 225 | 1 | 258 |
| 下载次数 | 被引频次 | 阅读次数 |
子宫肌瘤是女性生殖系统常见的良性肿瘤之一，好发于育龄期女性。近年来，由于各种因素导致子宫肌瘤的发病率呈逐渐上升趋势，其治疗方式呈现多样性。因为子宫肌瘤切除术创伤大、风险高、并发症多、恢复慢，因此，对于年轻有生育需求或者有保留子宫意愿的患者而言，如何缓解症状、减少复发、缩短妊娠等待时间成为目前迫切需要解决的问题。高强度聚焦超声消融是临床治疗子宫肌瘤较常见的物理方法，具有准确率高、创伤小、术后恢复快、无放射性污染及可重复性等优点，临床疗效较好，被广泛地应用于子宫肌瘤的临床治疗中。本文对近年来高强度聚焦超声消融治疗子宫肌瘤的相关研究进行综述，以便为临床上高强度聚焦超声消融治疗子宫肌瘤提供参考。
Abstract：Uterine fibroids are one of the most common benign tumors of the female reproductive system, predominantly affecting women of childbearing age. In recent years, various factors have contributed to a gradual increase in the incidence of uterine fibroids,and there are various treatment options available. Since uterine myomectomy is associated with significant trauma, high risks, multiple complications, and slow recovery, it has become an urgent clinical challenge to alleviate symptoms, reduce recurrence, and shorten the waiting time for pregnancy for young patients with fertility requirements or those who wish to preserve their uterus. High-intensity focused ultrasound(HIFU) ablation is a commonly used physical therapy for uterine fibroids in clinical practice, offering advantages such as high precision, minimal invasiveness, rapid postoperative recovery, absence of radioactive contamination, and repeatability. Its clinical efficacy is favorable, and it is widely applied in the treatment of uterine fibroids. This article reviews recent studies on the use of HIFU ablation surgery for uterine fibroids to provide a reference for its clinical application.
[1]Dai Y,Chen H,Yu J,et al. Global and regional trends in the incidence and prevalence of uterine fibroids and attributable risk factors at the national level from 2010 to2019:a worldwide database study[J]. Chin Med J(Engl),2024,137(21):2583-2589.
[2]娄诤，李春明，周坚红.子宫肌瘤病因与预防[J].实用妇产科杂志，2024,40(2):81-84.
[3]孙梦源，张国瑞，于昕.高强度聚焦超声消融联合促性腺激素释放激素激动剂治疗子宫肌瘤的临床疗效观察[J].生殖医学杂志，2024,33(8):1051-1057.
[4]周蓉.子宫肌瘤对生育力的影响及其围手术期保护[J].实用妇产科杂志，2024,40(2):84-87.
[5]Giuliani E, As-Sanie S, Marsh EE. Epidemiology and management of uterine fibroids[J]. Int J Gynaecol Obstet,2020,149(1):3-9.
[6]Krzyzanowski J, Wozniak S, Szkodziak P, et al. Minimally invasive treatment options for uterine fibroidsstate-of-the Art 2021[J]. Ginekol Pol, 2022, 93(3):242-247.
[7]Zhang G,Li L,Sun M,et al. Progress in high intensity focused ultrasound ablation for fertility preservation therapy of uterine fibroids and adenomyosis[J]. Reprod Sci,2025,32(1):15-25.
[8]孙慧敏，张蓓，杨军文.微创下子宫肌瘤治疗的研究进展[J].沈阳医学院学报，2023,25(6):639-643.
[9]何玉春.聚焦超声消融治疗子宫良性疾病的不良反应分析[D].遵义：遵义医科大学，2020.
[10]Ali MM, Raphael Mpehle C, Olusola E, et al. A systematic review of the side effects of high-intensity focused ultrasound ablation of uterine fibroids[J]. Proc(Bayl Univ Med Cent),2024,37(6):947-956.
[11]Jindal S, Jung J, Lee K, et al. High-intensity focused ultrasound for the treatment of fibroids:a single-center experience in singapore[J]. Gynecol Minim Invasive Ther,2023,12(1):15-25.
[12]Patel N, Chaudhari K, Patel D, et al. High-intensity focused ultrasound ablation of uterine fibroids:a review[J]. Cureus,2023,15(9):e44680.
[13]Laughlin-Tommaso S, Barnard EP, AbdElmagied AM,et al. FIRSTT study:randomized controlled trial of uterine artery embolization vs focused ultrasound surgery[J]. Am J Obstet Gynecol,2019,220(2):174,e1-174,e13.
[14]刘梦然，于晓兰.国际妇产科联盟3型子宫肌瘤的临床研究进展[J].中国实用妇科与产科杂志，2024,40(2):252-256.
[15]He Y, Wu M, Guo X, et al. Feasibility, safety and efficacy of high intensity focused ultrasound ablation as a preoperative treatment for challenging hysteroscopic myomectomy[J]. Int J Hyperthermia, 2024, 41(1):2365974.
[16]Qu K,Zou M,Wang Z,et al. Evaluation of the timing and safety of hysteroscopic myomectomy of large submucosal fibroids pretreated by high intensity focused ultrasound[J]. Int J Hyperthermia, 2023, 40(1):2249275.
[17]Wang Y, Liu X, Wang W, et al. Long-term clinical outcomes of US-guided high-intensity focused ultrasound ablation for symptomatic submucosal fibroids:a retrospective comparison with uterus-sparing surgery[J]. Acad Radiol,2021,28(8):1102-1107.
[18]Li W, Jiang Z, Deng X, et al. Long-term follow-up outcome and reintervention analysis of ultrasoundguided high intensity focused ultrasound treatment for uterine fibroids[J]. Int J Hyperthermia, 2020, 37(1):1046-1051.
[19]Wang Y, Gong C, He M, et al. Therapeutic dose and long-term efficacy of high-intensity focused ultrasound ablation for different types of uterine fibroids based on signal intensity on T2-weighted MR images[J]. Int J Hyperthermia,2023,40(1):2194594.
[20]Gong C,Lin Z,Lv F,et al. Magnetic resonance imaging parameters in predicting the ablative efficiency of highintensity focused ultrasound for uterine fibroids[J]. Int J Hyperthermia,2021,38(1):523-531.
[21]Jin J, Zhao Y, Huang P. Combination of HIFU with sulfur hexafluoride microbubbles in the treatment of solitary uterine fibroids:a systematic review and metaanalysis[J]. Eur Radiol,2024,34(6):3786-3794.
[22]Jiang Z, Li Q, Li W, et al. A comparative analysis of pregnancy outcomes of patients with uterine fibroids after high intensity focused ultrasound ablation and laparoscopic myomectomy:a retrospective study[J]. Int J Hyperthermia,2021,38(1):79-84.
[23]朱燕.高强度聚焦超声消融与腹腔镜手术治疗子宫肌瘤效果比较研究[J].河南外科学杂志，2024,30(1):164-166.
[24]Hu Y, Song X, Xu L, et al. High-intensity focused ultrasound is a better choice for women with fertility desire:a systematic review and meta-analysis of the comparison between high-intensity focused ultrasound and laparoscopic treatment of uterine fibroids[J]. Gynecol Minim Invasive Ther,2023,13(2):79-89.
[25]Wu G,Li R,He M,et al. A comparison of the pregnancy outcomes between ultrasound-guided high-intensity focused ultrasound ablation and laparoscopic myomectomy for uterine fibroids:a comparative study[J]. Int J Hyperthermia,2020,37(1):617-623.
[26]Ji J, Liu J, Chen Y, et al. Analysis of high intensity focused ultrasound in treatment of uterine fibroids on ovarian function and pregnancy outcome[J]. J Clin Ultrasound,2022,50(2):202-208.
[27]Matlac DM, Tonguc T, Mutschler N, et al. Study protocol of a prospective,monocentric,single-arm study investigating the safety and efficacy of local ablation of symptomatic uterine fibroids with US-guided highintensity focused ultrasound(HIFU)[J]. J Clin Med,2023,12(18):5926.
[28]Lu SS, Yang LL, Yang W, et al. Complications and adverse events of high-intensity focused ultrasound in its application to gynecological field–a systematic review and meta-analysis[J]. Int J Hyperthermia,2024,41(1):2370969.
[29]Kociuba J，?oziński T, Zgliczyńska M, et al. Adverse events and complications after magnetic resonanceguided focused ultrasound(MRgFUS)therapy in uterine fibroids-a systematic review and future perspectives[J]. Int J Hyperthermia,2023,40(1):2174274.
[30]中国医师协会聚焦超声消融手术临床应用技术规范制定专家委员会.聚焦超声消融手术临床应用技术规范专家共识（2020年版）[J].中华医学杂志，2020,100(13):974-977.
[31]Kociuba J，?oziński T,Zgliczyńska M,et al. Occurrence of adverse events after magnetic resonance-guided highintensity focused ultrasound(MR-HIFU)therapy in symptomatic uterine fibroids-a retrospective case-control study[J]. Int J Hyperthermia,2023,40(1):2219436.
[32]Jeng CJ, Ou KY, Long CY, et al. 500 cases of highintensity focused ultrasound(HIFU)ablated uterine fibroids and adenomyosis[J]. Taiwan J Obstet Gynecol,2020,59(6):865-871.
基本信息:
DOI：10.19757/j.cnki.issn1674-7763.2025.04.016
中图分类号:R737.33
引用信息:
[1]刘一斐,李伟,王丽琴.高强度聚焦超声消融治疗子宫肌瘤的研究进展[J].中国妇幼卫生杂志,2025,16(04):343-347.DOI:10.19757/j.cnki.issn1674-7763.2025.04.016.
基金信息:
2022年度自治区卫生健康科技计划项目(202202091)
2025-08-20
2025-08-20